Forget about saving British big pharma – it’s little pharma we should be helping

Readers in all sorts of places — at the club bar, over a birthday lunch, even along the church pew — had been telling me I was wrong not to subscribe to the ‘save AstraZeneca’ campaign, and too complacent about the future of British science when I wrote: ‘the game is Pfizer’s for the taking, as soon as the price is right’.

Already a subscriber? Log in

Get 10 issues
for $10

Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.

Delivery of the weekly magazine
Unlimited access to spectator.com.au and app
Spectator podcasts and newsletters
Full access to spectator.co.uk

Unlock this article

TaggedAstraZeneca, Emma Duncan, Pfizer, pharma, Recession, saving the high street, Sunday Times Rich List, superstores, town centres

Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Forget about saving British big pharma – it's little pharma we should be helping

Plus: In praise of the high street, and why the Rich List should be a set text for sixth-formers

Get 10 issues
for $10